Ditchcarbon
  • Customers
  1. Organizations
  2. Merck And Co
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 4 days ago

Merck And Co

Company website

Merck & Co., Inc., commonly referred to as Merck, is a leading global healthcare company headquartered in the United States. Founded in 1891, Merck has established itself as a pioneer in the pharmaceutical industry, focusing on innovative medicines, vaccines, and biologic therapies. With a strong presence in North America, Europe, and Asia, the company is dedicated to improving health outcomes worldwide. Merck's core products include groundbreaking treatments in oncology, infectious diseases, and vaccines, notably the HPV vaccine Gardasil and the cancer immunotherapy Keytruda. These offerings are distinguished by their commitment to research and development, which has led to numerous key milestones in medical advancements. As a market leader, Merck consistently ranks among the top pharmaceutical companies globally, recognised for its contributions to public health and its robust pipeline of future therapies.

DitchCarbon Score

How does Merck And Co's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

75

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Merck And Co's score of 75 is higher than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.

86%

Let us know if this data was useful to you

Merck And Co's reported carbon emissions

In 2023, Merck & Co., headquartered in the US, reported total carbon emissions of approximately 7,527,700,000 kg CO2e. This figure includes 718,400,000 kg CO2e from Scope 1 emissions, 184,200,000 kg CO2e from market-based Scope 2 emissions, and a significant 6,625,100,000 kg CO2e from Scope 3 emissions. The Scope 3 emissions breakdown reveals major contributions from purchased goods and services (5,107,100,000 kg CO2e) and business travel (420,800,000 kg CO2e). Merck has set ambitious climate commitments, aiming for carbon neutrality across its operations (Scopes 1 and 2) by 2025. Additionally, the company has pledged to reduce absolute Scope 1 and Scope 2 GHG emissions by 46% by 2030, using 2019 as the baseline year. This target includes biogenic emissions and removals from bioenergy feedstocks. Furthermore, Merck is committed to a 30% reduction in absolute Scope 3 emissions within the same timeframe. The company is also part of the Science Based Targets initiative (SBTi), which validates its targets as consistent with the reductions required to limit global warming to 1.5°C. Long-term, Merck aims to achieve net-zero emissions across all scopes by 2045, with a 90% reduction in absolute emissions from 2019 levels by that year. Overall, Merck & Co. is actively working towards significant emissions reductions and has established a clear framework for achieving its climate goals.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20132014201520162017201820192020202120222023
Scope 1
417,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 2
367,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 3
64,000,000
000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Merck And Co's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Merck And Co is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Merck And Co is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

GlaxoSmithKline Pharmaceuticals Limited

IN
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Pfizer

US
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Kyorin Pharmaceutical

JP
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Novartis Pharmaceuticals Corporation

US
•
Pharmaceutical Preparation Manufacturing
Updated 8 days ago

Glaxosmithkline

GB
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Abbvie

US
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250731.5
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy